Clinical Trial Update: A Study of Immediate 9 Months Adjuvant Hormone Therapy With Triptorelin 11.25 mg Versus Active Surveillance After Radical Prostatectomy in High Risk Prostate Cancer Patients. [Phase 4]

View source ↗

Summary

Phase 4 trial comparing immediate 9-month adjuvant hormone therapy with triporelin versus active surveillance after radical prostatectomy in high-risk prostate …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Triptorelin 11.25 mg (triptorelin)

Snippet

Sponsor: Ipsen | Conditions: Prostate Cancer | Phase 4 | Status: COMPLETED | Results posted: 2020-12-09